Halberd Co. (OTCMKTS:HALB) Short Interest Up 2,100.0% in July

Halberd Co. (OTCMKTS:HALB) was the recipient of a significant growth in short interest in the month of July. As of July 31st, there was short interest totaling 8,800 shares, agrowthof2,100.0% from the July 15th total of 400 shares. Based on an average trading volume of 1,338,500 shares, the short-interest ratio is presently 0.0 days. Based on an average trading volume of 1,338,500 shares, the short-interest ratio is presently 0.0 days.

Halberd Stock Down 9.5%

Shares of Halberd stock opened at $0.00 on Friday. Halberd has a 52 week low of $0.00 and a 52 week high of $0.01.

Halberd Company Profile

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.